Related Experiment Video
Updated: Jul 11, 2025

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
Probiotic responder identification in cross-over trials for constipation using a Bayesian statistical model
Shion Hosoda1,2, Yuichiro Nishimoto3, Yohsuke Yamauchi3
1Department of Electrical Engineering and Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan.
This study introduces a new Bayesian model to accurately identify responders to probiotic treatments for constipation by accounting for the time delay between intake and effect. The model improves upon previous methods by considering this crucial lag period.
Area of Science:
- Microbiome research
- Statistical modeling
- Gastroenterology
Background:
- Microbial interventions like probiotics show promise for constipation.
- Probiotic efficacy varies individually, necessitating responder identification.
- Existing statistical models for responders do not account for intake-to-effect lag time.
Purpose of the Study:
- To develop a Bayesian statistical model for estimating responder probability in probiotic interventions.
- To incorporate the lag period between probiotic intake and observed effects into the model.
- To improve the accuracy of identifying individuals who respond to specific probiotics.
Main Methods:
- Proposed a Bayesian statistical model to estimate responder probability.
- Included a parameter to account for the lag between probiotic administration and effect onset.
- Evaluated model performance using synthetic datasets.
Main Results:
- The proposed Bayesian model outperformed a base model that did not consider lag time.
- The model successfully identified responders, even those with significant uncertainty in lag periods.
- Demonstrated improved accuracy in responder evaluation for microbial interventions.
Conclusions:
- The developed Bayesian model offers a more accurate method for evaluating probiotic responders.
- Accounting for lag time is crucial for precise responder identification in microbiome-based therapies.
- This model advances the personalized approach to probiotic treatment for constipation and other conditions.
More Related Videos
07:45Preparation and Maintenance of Bioexclusion IsoPositive Cage Experiment for Human Fecal Transplantation into Germ-Free Mice
Published on: February 28, 2025
08:53Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...